trial · primary record
MGC026 Dose Escalation
Advanced Solid Tumor
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 394 |
| Primary completion | 2029-04 |
| Primary endpoint | Number of participants with adverse events (AEs) and serious AEs (SAEs), AEs leading to dose delay, AEs leading to dose reduction, AEs leading to treatment discontinuations, AEs meeting criteria for dose limiting toxicity, and AEs of special interest. |
| Registry ID | NCT06242470 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:42:59.988Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06242470
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.